Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$21,991,008
+$994,590 QoQ
Shares Held
86,589
+0.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#706
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. JNJ ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
|
1,564 | $393,564 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,991,008 | 86,589 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,996,418 | 85,896 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,284,653 | 88,353 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,081,847 | 86,732 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,276,113 | 86,914 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $14,604,202 | 88,062 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,822,053 | 116,319 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,587,633 | 114,696 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,434,522 | 112,442 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,636,842 | 105,170 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,986,538 | 95,614 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,064,536 | 90,302 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $14,243,823 | 86,055 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $12,743,945 | 82,219 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,281,799 | 80,848 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,973,071 | 79,414 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,840,454 | 77,970 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,542,675 | 76,413 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,659,008 | 73,999 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,368,469 | 70,393 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,659,666 | 64,706 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,634,431 | 64,706 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,541,319 | 60,626 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $8,624,469 | 57,929 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $8,143,742 | 57,909 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,762,896 | 59,200 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||